Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein

The baculovirus-insect cell expression system is readily utilized to produce viral glycoproteins for research as well as for subunit vaccines and vaccine candidates, for instance against SARS-CoV-2 infections. However, the glycoforms of recombinant proteins derived from this expression system are in...

Full description

Bibliographic Details
Main Authors:	Johannes Ruhnau, Valerian Grote, Mariana Juarez-Osorio, Dunja Bruder, Reza Mahour, Erdmann Rapp, Thomas F. T. Rexer, Udo Reichl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	SARS-CoV-2 COVID- 19 glycoengineering subunit vaccine cell-free synthetic biology
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2021.699025/full

Similar Items

Cell-free N-glycosylation of peptides using synthetic lipid-linked hybrid and complex N-glycans
by: Lisa Wenzel, et al.
Published: (2023-09-01)

Labeling glycans on living cells by a chemoenzymatic glycoengineering approach
by: Ruben T. Almaraz, et al.
Published: (2017-06-01)

Strategies for Glycoengineering Therapeutic Proteins
by: Kris Dammen-Brower, et al.
Published: (2022-04-01)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
by: Shasha Li, et al.
Published: (2021-11-01)

Harnessing Plant Sugar Metabolism for Glycoengineering
by: Sophia N. Tang, et al.
Published: (2023-12-01)

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines
by: Sherif Abouelhadid, et al.
Published: (2023-08-01)

Removable Dyes—The Missing Link for In-Depth N-Glycan Analysis via Multi-Method Approaches
by: Samanta Cajic, et al.
Published: (2023-07-01)

Protein Glycoengineering: An Approach for Improving Protein Properties
by: Bo Ma, et al.
Published: (2020-07-01)

Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
by: Ian J. Passmore, et al.
Published: (2019-01-01)

A versatile design platform for glycoengineering therapeutic antibodies
by: Seth D. Ludwig, et al.
Published: (2022-12-01)

The Applications of Metabolic Glycoengineering
by: Liwei Ying, et al.
Published: (2022-02-01)

Applying Acylated Fucose Analogues to Metabolic Glycoengineering
by: Julia Rosenlöcher, et al.
Published: (2015-11-01)

Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified <i>N</i>-Acetylmannosamine (ManNAc) Analogs
by: Jian Du, et al.
Published: (2021-02-01)

In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor
by: Lars Radke, et al.
Published: (2017-08-01)

Bioorthogonal metabolic glycoengineering of human larynx carcinoma (HEp-2) cells targeting sialic acid
by: Arne Homann, et al.
Published: (2010-03-01)

Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli
by: Emily J. Kay, et al.
Published: (2016-01-01)

A Markov model of glycosylation elucidates isozyme specificity and glycosyltransferase interactions for glycoengineering
by: Chenguang Liang, et al.
Published: (2020-11-01)

Generation of an azide-modified extracellular matrix by adipose-derived stem cells using metabolic glycoengineering
by: Nellinger Svenja, et al.
Published: (2019-09-01)

Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approach
by: Joanna Hajduk, et al.
Published: (2020-01-01)

Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
by: Stephan Altmann, et al.
Published: (2021-03-01)

Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody
by: David Falck, et al.
Published: (2021-01-01)

Improving Schwann Cell Differentiation from Human Adipose Stem Cells with Metabolic Glycoengineering
by: Jian Du, et al.
Published: (2023-04-01)

Exploiting the <it>Campylobacter jejuni </it>protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis
by: Iwashkiw Jeremy A, et al.
Published: (2012-01-01)

Enzymatic Cascades for Tailored <sup>13</sup>C<sub>6</sub> and <sup>15</sup>N Enriched Human Milk Oligosaccharides
by: Thomas Fischöder, et al.
Published: (2019-09-01)

Metabolic Glycoengineering Enables the Ultrastructural Visualization of Sialic Acids in the Glycocalyx of the Alveolar Epithelial Cell Line hAELVi
by: Raphael Brandt, et al.
Published: (2021-01-01)

Impact of different influenza cultivation conditions on HA <it>N</it>-Glycosylation
by: Roedig Jana V, et al.
Published: (2011-11-01)

The Impact of Glycoengineering on the Endoplasmic Reticulum Quality Control System in Yeasts
by: Mari A. Piirainen, et al.
Published: (2022-06-01)

Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria
by: Fenryco Pratama, et al.
Published: (2021-10-01)

Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseases
by: Gyeong Taek Lim, et al.
Published: (2021-03-01)

A Delta–Omicron Bivalent Subunit Vaccine Elicited Antibody Responses in Mice against Both Ancestral and Variant Strains of SARS-CoV-2
by: Tiantian Wang, et al.
Published: (2023-09-01)

A bivalent subunit vaccine efficiently produced in Pichia pastoris against SARS-CoV-2 and emerging variants
by: Huifang Xu, et al.
Published: (2023-01-01)

A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
by: Saehyung Lee, et al.
Published: (2019-01-01)

Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins
by: Alexander Pralow, et al.
Published: (2021-03-01)

PROTEIN GLYCOSYLATION IN BACTERIAL CELLS AND ITS POTENTIAL APPLICATIONS
by: Agnieszka Wyszyńska, et al.
Published: (2021-06-01)

Reliable <i>N</i>-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation
by: Robert Burock, et al.
Published: (2023-02-01)

Production of Recombinant Human Ceruloplasmin: Improvements and Perspectives
by: Maria Carmela Bonaccorsi di Patti, et al.
Published: (2021-07-01)

Engineering Escherichia coli for increased Und-P availability leads to material improvements in glycan expression technology
by: Emily J. Kay, et al.
Published: (2024-03-01)

In planta deglycosylation improves the SARS-CoV-2 neutralization activity of recombinant ACE2-Fc
by: Shiva Izadi, et al.
Published: (2023-05-01)

Artificial and Natural Sialic Acid Precursors Influence the Angiogenic Capacity of Human Umbilical Vein Endothelial Cells
by: Sebastian P. Galuska, et al.
Published: (2013-02-01)

Editorial: Glycotherapeutics: Design, synthesis, function and biomedical application of agents emerging from glycochemistry and glycobiology
by: M. Osman Sheikh, et al.
Published: (2022-09-01)